On the 23rd and 24th of April 2024, SPI –Sociedade Portuguesa de Inovação, as the leader of Work Package 5 – Dissemination, Exploitation and Communication participated in the 2nd GlycanTrigger General Assembly Meeting. The consortium meeting took place at Leiden University Medical Center, in Leiden, Netherlands.

 

O GlycanTrigger it is a project funded by the European Commission under the Horizon Europe programme, and aims to understand how changes in the intestinal glycome trigger the transition from a healthy state to chronic inflammation. The project is coordinated by Institute for Research and Innovation in Health (i3S) and brings together 9 organisations from 6 different European countries (Belgium, France, Germany, Portugal, the Netherlands and the United Kingdom) and 1 non-European country (United States of America).

 

The two-day meeting served to address the project's current progress and its challenges, as well as to define its next steps. SPI, represented by Diana Sousa and Francisco Rocha, took the opportunity to present GlycanTrigger's communication and dissemination activities, and its future approach to organising a series of workshops and webinars aimed at patients with inflammatory bowel disease.

 

For more information about GlycanTrigger, please visit: https://glycantrigger.eu/